PDM-ProValue meets cardiovascular outcome trials in diabetes
Abstract Novel studies have increased our knowledge regarding optimal treatment options in diabetes. Key studies that have broadened our knowledge about optimal treatment options in diabetes in recent years are cardiovascular outcome trials (CVOTs) and studies investigating aspects of digitalisation...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12933-019-0815-3 |
id |
doaj-3251211b158148b9a640da8437719faa |
---|---|
record_format |
Article |
spelling |
doaj-3251211b158148b9a640da8437719faa2020-11-25T01:28:36ZengBMCCardiovascular Diabetology1475-28402019-01-011811710.1186/s12933-019-0815-3PDM-ProValue meets cardiovascular outcome trials in diabetesKatharina Fritzen0Oliver Schnell1Sciarc GmbHForschergruppe Diabetes e.V.Abstract Novel studies have increased our knowledge regarding optimal treatment options in diabetes. Key studies that have broadened our knowledge about optimal treatment options in diabetes in recent years are cardiovascular outcome trials (CVOTs) and studies investigating aspects of digitalisation and monitoring of glucose (e.g. PDM-ProValue). We aimed at highlighting similarities between the two important pillars for a successful diabetes management. We emphasise the need for a consideration of both approaches in future clinical trial designs and protocols.http://link.springer.com/article/10.1186/s12933-019-0815-3PDM-ProValueiPDMCVOTsDiabetesSMBG |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Katharina Fritzen Oliver Schnell |
spellingShingle |
Katharina Fritzen Oliver Schnell PDM-ProValue meets cardiovascular outcome trials in diabetes Cardiovascular Diabetology PDM-ProValue iPDM CVOTs Diabetes SMBG |
author_facet |
Katharina Fritzen Oliver Schnell |
author_sort |
Katharina Fritzen |
title |
PDM-ProValue meets cardiovascular outcome trials in diabetes |
title_short |
PDM-ProValue meets cardiovascular outcome trials in diabetes |
title_full |
PDM-ProValue meets cardiovascular outcome trials in diabetes |
title_fullStr |
PDM-ProValue meets cardiovascular outcome trials in diabetes |
title_full_unstemmed |
PDM-ProValue meets cardiovascular outcome trials in diabetes |
title_sort |
pdm-provalue meets cardiovascular outcome trials in diabetes |
publisher |
BMC |
series |
Cardiovascular Diabetology |
issn |
1475-2840 |
publishDate |
2019-01-01 |
description |
Abstract Novel studies have increased our knowledge regarding optimal treatment options in diabetes. Key studies that have broadened our knowledge about optimal treatment options in diabetes in recent years are cardiovascular outcome trials (CVOTs) and studies investigating aspects of digitalisation and monitoring of glucose (e.g. PDM-ProValue). We aimed at highlighting similarities between the two important pillars for a successful diabetes management. We emphasise the need for a consideration of both approaches in future clinical trial designs and protocols. |
topic |
PDM-ProValue iPDM CVOTs Diabetes SMBG |
url |
http://link.springer.com/article/10.1186/s12933-019-0815-3 |
work_keys_str_mv |
AT katharinafritzen pdmprovaluemeetscardiovascularoutcometrialsindiabetes AT oliverschnell pdmprovaluemeetscardiovascularoutcometrialsindiabetes |
_version_ |
1725100635511062528 |